https://orcid.org/0000-0003-2398-1254
Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Mai H. ElNaggar, Abdullah A. Elgazar, Ghada Gamal, Shimaa M. Hamed, Zainab M. Elsayed, Mohamed K. El-Ashrey, Amira Abood, Mahmoud A. El Hassab, Ahmed M. Soliman, Ramadan A. El-Domany, Farid A. Badria, Claudiu T. Supuran & Wagdy M. Eldehna. (2023) Identification of sulphonamide-tethered N-((triazol-4-yl)methyl)isatin derivatives as inhibitors of SARS-CoV-2 main protease. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Read now
Clemente Capasso & Claudiu T. Supuran. (2023) The management of Babesia, amoeba and other zoonotic diseases provoked by protozoa. Expert Opinion on Therapeutic Patents 33:3, pages 179-192.
Read now
Read now
Claudiu T. Supuran. (2023) Antiprotozoal drugs: challenges and opportunities. Expert Opinion on Therapeutic Patents 33:3, pages 133-136.
Read now
Read now
Debasis Mitra, Devvret Verma, Bhaswatimayee Mahakur, Anshul Kamboj, Rakesh Srivastava, Sugam Gupta, Ajita Pandey, Bhawna Arora, Kumud Pant, P. Panneerselvam, Arabinda Ghosh, Durga P. Barik & Pradeep K. Das Mohapatra. (2022) Molecular docking and simulation studies of natural compounds of Vitex negundo L. against papain-like protease (PLpro) of SARS CoV-2 (coronavirus) to conquer the pandemic situation in the world. Journal of Biomolecular Structure and Dynamics 40:12, pages 5665-5686.
Read now
Read now
Alessio Nocentini, Clemente Capasso & Claudiu T. Supuran. (2022) Perspectives on the design and discovery of α-ketoamide inhibitors for the treatment of novel coronavirus: where do we stand and where do we go?. Expert Opinion on Drug Discovery 17:6, pages 547-557.
Read now
Read now
Claudiu T. Supuran. (2021) Coronaviruses. Expert Opinion on Therapeutic Patents 31:4, pages 291-294.
Read now
Read now
Jacopo Cusinato, Ylenia Cau, Anna Maria Calvani & Mattia Mori. (2021) Repurposing drugs for the management of COVID-19. Expert Opinion on Therapeutic Patents 31:4, pages 295-307.
Read now
Read now
Clemente Capasso, Alessio Nocentini & Claudiu T Supuran. (2021) Protease inhibitors targeting the main protease and papain-like protease of coronaviruses. Expert Opinion on Therapeutic Patents 31:4, pages 309-324.
Read now
Read now
Secil Deniz, Tugba Kevser Uysal, Clemente Capasso, Claudiu T. Supuran & Ozen Ozensoy Guler. (2021) Is carbonic anhydrase inhibition useful as a complementary therapy of Covid-19 infection?. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1230-1235.
Read now
Read now
Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay & Mohamed Gomaa Kamel. (2020) Possible therapeutic agents for COVID-19: a comprehensive review. Expert Review of Anti-infective Therapy 18:10, pages 1005-1020.
Read now
Read now
Claudiu T. Supuran. (2020) Coumarin carbonic anhydrase inhibitors from natural sources. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1462-1470.
Read now
Read now
Articles from other publishers (12)
M. Nawaz Sharif, M. Ajmal Khan, Qamar Wali, Khalid Ayub, Malika Rani, Fang Wang & Yuhuai Liu. (2023) Tunnelling assisted by Si-doped n-AlGaN layer on the p-side of 254 nm DUV LED. Optical and Quantum Electronics 55:9.
Crossref
Crossref
Umberto Molini, Lauren M. Coetzee, Tanya Engelbrecht, Lourens de Villiers, Mari de Villiers, Iolanda Mangone, Valentina Curini, Siegfried Khaiseb, Massimo Ancora, Cesare Cammà, Alessio Lorusso & Giovanni Franzo. (2022) SARS-CoV-2 in Namibian Dogs. Vaccines 10:12, pages 2134.
Crossref
Crossref
Mohammad Khalid, Anas Alshishani & Yousef Al-ebini. (2022) Genome Similarities between Human-Derived and Mink-Derived SARS-CoV-2 Make Mink a Potential Reservoir of the Virus. Vaccines 10:8, pages 1352.
Crossref
Crossref
K. Najberek, A. Olszańska, B. Tokarska-Guzik, K. Mazurska, Z. Dajdok & W. Solarz. (2022) Invasive alien species as reservoirs for pathogens. Ecological Indicators 139, pages 108879.
Crossref
Crossref
Aziz Ul‐Rahman, Hafiz Muhammad Ishaq, Muhammad Asif Raza & Muhammad Zubair Shabbir. (2021) Zoonotic potential of Newcastle disease virus: Old and novel perspectives related to public health. Reviews in Medical Virology 32:1.
Crossref
Crossref
Ankur Gupta, Anish Pradhan, Vimal K. Maurya, Swatantra Kumar, Angila Theengh, Bipin Puri & Shailendra K. Saxena. (2021) Therapeutic approaches for SARS-CoV-2 infection. Methods 195, pages 29-43.
Crossref
Crossref
Shahab Mahmoudvand & Somayeh Shokri. (2021) Interactions between SARS coronavirus 2 papain‐like protease and immune system: A potential drug target for the treatment of COVID‐19. Scandinavian Journal of Immunology 94:4.
Crossref
Crossref
Myndi G. Holbrook, Simon J. Anthony, Isamara Navarrete-Macias, Theo Bestebroer, Vincent J. Munster & Neeltje van Doremalen. (2021) Updated and Validated Pan-Coronavirus PCR Assay to Detect All Coronavirus Genera. Viruses 13:4, pages 599.
Crossref
Crossref
Jones Andrade, Paulo Fernando Bruno Gonçalves & Paulo Augusto Netz. (2020) Why Does the Novel Coronavirus Spike Protein Interact so Strongly with the Human ACE2? A Thermodynamic Answer. ChemBioChem 22:5, pages 865-875.
Crossref
Crossref
Alane Beatriz Vermelho, Mattia Mori, William A. Donald & Claudiu T. Supuran. 2022. Antiprotozoal Drug Development and Delivery. Antiprotozoal Drug Development and Delivery
321
329
.
Francesca Picarazzi, Ilaria Vicenti, Francesco Saladini, Maurizio Zazzi & Mattia Mori. (2020) Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge. Molecules 25:23, pages 5695.
Crossref
Crossref
Mattia Mori, Stefano Ciaco, Yves Mély & Anastasia Karioti. (2020) Inhibitory Effect of Lithospermic Acid on the HIV-1 Nucleocapsid Protein. Molecules 25:22, pages 5434.
Crossref
Crossref